Launching a drug in the rare disease arena involves a unique and specialized approach, compared to more common conditions. Rare disease drugs may involve cutting-edge therapies—such as Gene Therapies— necessitating training on unique method of action (MOA) and novel delivery mechanisms.
At Omni Tech Medical, we provide the expertise and resources that your team needs, with a high level of scientific knowledge, as many health care providers may have limited experience with these conditions compared to more prevalent diseases. Stakeholders need to understand the dynamics of the patient population, focus on education and awareness, inform the whole medical office, and engage in discussions with payers.
With Omni Tech Medical, your team becomes much more than just a service provider—they become educators, leaders, and trusted voices in the rare disease community.
Across the clinic
Everything in rare diseases is new. Rare is like that. Yours sales teams and MSLs should offer a guiding hand across the whole medical office. Physicians need prevalence, MOAs, and treatment options. Technologists ask what’s special about what they’re seeing. Nurses have to understand their patients’ journeys, from onset to aftercare.
Across the community
Really professional sales teams are part of the thought-community. They have solid working relationships with key opinion leaders, clinical talent, technical experts, and peer influencers. Give them functional breakout workshops and supporting modules. Expert knowledge isn’t just for the clinic. It extends for all the way out to the patient community and their families.
You’re the teacher!
It may sound strange to guide a doctor’s diagnosis, but in a rare disease it’s necessary. Your people know things the doctors don’t know, about disease prevalence, risk factors, differential diagnoses, and treatment options. That’s why we advocate a concept launch before the usual product launch. In rare disease, you have to prepare your audience.
